Bin Lan

802 total citations
36 papers, 551 citations indexed

About

Bin Lan is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Bin Lan has authored 36 papers receiving a total of 551 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 11 papers in Oncology and 7 papers in Immunology. Recurrent topics in Bin Lan's work include Cancer Immunotherapy and Biomarkers (5 papers), Cell death mechanisms and regulation (3 papers) and Immunotherapy and Immune Responses (3 papers). Bin Lan is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), Cell death mechanisms and regulation (3 papers) and Immunotherapy and Immune Responses (3 papers). Bin Lan collaborates with scholars based in China, United States and Italy. Bin Lan's co-authors include Shaowu Cheng, Biao Tang, Chao He, Xi‐Long Zheng, Jun Liao, Guozuo Wang, Jinwen Ge, Fang Guo, Xuefeng Wang and Biao Jiang and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Clinical Cancer Research.

In The Last Decade

Bin Lan

35 papers receiving 548 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bin Lan China	12	250	181	176	97	75	36	551
Harika Sabbineni United States	12	344 1.4×	94 0.5×	98 0.6×	78 0.8×	66 0.9×	16	535
Jian Pang China	15	341 1.4×	194 1.1×	104 0.6×	182 1.9×	132 1.8×	34	700
Ilaria Craparotta Italy	13	245 1.0×	117 0.6×	82 0.5×	167 1.7×	100 1.3×	25	539
Si Yang China	17	455 1.8×	206 1.1×	109 0.6×	95 1.0×	51 0.7×	43	702
Lin Xiao China	14	248 1.0×	134 0.7×	102 0.6×	107 1.1×	22 0.3×	57	513
Andrew Trotta Australia	13	453 1.8×	154 0.9×	122 0.7×	125 1.3×	92 1.2×	17	693
Ting Gong China	13	384 1.5×	178 1.0×	84 0.5×	89 0.9×	110 1.5×	29	644
Xiuzhi Duan China	13	264 1.1×	130 0.7×	109 0.6×	99 1.0×	49 0.7×	33	526
Chen Luo China	15	319 1.3×	202 1.1×	97 0.6×	103 1.1×	65 0.9×	39	553
Yuan Ma China	13	380 1.5×	179 1.0×	57 0.3×	98 1.0×	95 1.3×	19	584

Countries citing papers authored by Bin Lan

Since Specialization

Citations

This map shows the geographic impact of Bin Lan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bin Lan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bin Lan more than expected).

Fields of papers citing papers by Bin Lan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bin Lan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bin Lan. The network helps show where Bin Lan may publish in the future.

Co-authorship network of co-authors of Bin Lan

This figure shows the co-authorship network connecting the top 25 collaborators of Bin Lan. A scholar is included among the top collaborators of Bin Lan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bin Lan. Bin Lan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lan, Bin, et al.. (2025). Research advances of PANoptosis in gastrointestinal tumors. International Immunopharmacology. 159. 114931–114931. 3 indexed citations

Lin, Jing, et al.. (2025). DNA-PKcs Dysfunction Enhances the Antitumor Activity of Radioimmunotherapy by Activating the cGAS-STING Pathway in HNSCC. Journal of Inflammation Research. Volume 18. 4177–4193. 1 indexed citations

Lan, Bin, et al.. (2023). AR-A014418 regulates intronic polyadenylation and transcription of PD-L1 through inhibiting CDK12 and CDK13 in tumor cells. Journal for ImmunoTherapy of Cancer. 11(5). e006483–e006483. 6 indexed citations

Lan, Bin, et al.. (2023). Effect of Polyamidoamine-Dendrimer Nanoparticles Combined with Human Umbilical Vein Endothelial Cell Microenvironment on the Growth and Immune Infiltration of Nasopharyngeal Carcinoma Cell Line CNE-1. Science of Advanced Materials. 15(9). 1224–1233. 1 indexed citations

Wang, Xuefeng, Yu Chen, Bin Lan, et al.. (2022). Heterogeneity of tyrosine-based melanin anabolism regulates pulmonary and cerebral organotropic colonization microenvironment of melanoma cells. Theranostics. 12(5). 2063–2079. 12 indexed citations

Li, Shuai, Yi Liu, Xinyi Liu, et al.. (2021). Magnetite Fe3O4 Nanoparticles Enhance Mild Microwave Ablation of Tumor by Activating the IRE1-ASK1-JNK Pathway and Inducing Endoplasmic Reticulum Stress. International Journal of Nanomedicine. Volume 16. 6129–6140. 7 indexed citations

Chen, Yu, Yi Li, Bin Lan, et al.. (2021). Role of PRKDC in cancer initiation, progression, and treatment. Cancer Cell International. 21(1). 563–563. 30 indexed citations

Lan, Bin, Jinwen Ge, Shaowu Cheng, et al.. (2020). Extract of Naotaifang, a compound Chinese herbal medicine, protects neuron ferroptosis induced by acute cerebral ischemia in rats. Journal of Integrative Medicine. 18(4). 344–350. 106 indexed citations

Lan, Bin, et al.. (2020). Cross Talk Between Ferroptosis and Cerebral Ischemia. Frontiers in Neuroscience. 14. 776–776. 56 indexed citations

10.

Wang, Xuefeng, Liangyu Lin, Bin Lan, et al.. (2020). IGF2R-initiated proton rechanneling dictates an anti-inflammatory property in macrophages. Science Advances. 6(48). 43 indexed citations

11.

Zou, Chen, Hao Qiu, Weifeng Tang, et al.. (2018). <em>CTLA4</em> tagging polymorphisms and risk of colorectal cancer: a case–control study involving 2,306 subjects. OncoTargets and Therapy. Volume 11. 4609–4619. 26 indexed citations

12.

Song, Zhenyan, et al.. (2018). Systems Pharmacological Approach to Investigate the Mechanism ofAcori Tatarinowii Rhizomafor Alzheimer’s Disease. Evidence-based Complementary and Alternative Medicine. 2018(1). 5194016–5194016. 26 indexed citations

13.

Lan, Bin, et al.. (2018). Combination therapy with BH3 mimetic and hyperthermia tends to be more effective on anti-melanoma treatment. Biochemical and Biophysical Research Communications. 503(1). 249–256. 6 indexed citations

14.

Li, Ruixiong, et al.. (2017). Preventing graft restenosis after coronary artery bypass grafting with tissue-type plasminogen activator. European journal of medical research. 22(1). 18–18. 6 indexed citations

15.

Yan, Xiangming, Bin Lan, Xiaohu Li, et al.. (2016). Molecular mechanisms of synergistic induction of apoptosis by the combination therapy with hyperthermia and cisplatin in prostate cancer cells. Biochemical and Biophysical Research Communications. 479(2). 159–165. 15 indexed citations

16.

Wang, Xuefeng, Chen Zhang, Xiangming Yan, et al.. (2015). A Novel Bioavailable BH3 Mimetic Efficiently Inhibits Colon Cancer via Cascade Effects of Mitochondria. Clinical Cancer Research. 22(6). 1445–1458. 28 indexed citations

17.

Lan, Bin, Jian Zhang, Dong Lu, & Wenqin Li. (2015). Generation of cancer-specific CD8+ CD69+ cells inhibits colon cancer growth. Immunobiology. 221(1). 1–5. 7 indexed citations

18.

Lin, Yingying, Yongming Qiu, Cheng Xu, et al.. (2014). Functional Role of Asparaginyl Endopeptidase Ubiquitination by TRAF6 in Tumor Invasion and Metastasis. JNCI Journal of the National Cancer Institute. 106(4). dju012–dju012. 86 indexed citations

19.

Li, Ruixiong, et al.. (2013). Differential expression of tissue-type plasminogen activator in restenosis animal blood vessel. 19(3). 216–219. 1 indexed citations

20.

Lan, Bin, Yanlong Yang, Ruixiong Li, et al.. (2013). ECM-related gene expression profile in vascular smooth muscle cells from human saphenous vein and internal thoracic artery. Journal of Cardiothoracic Surgery. 8(1). 155–155. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact